articleThe Lancet Child & Adolescent HealthJan 9, 2023GREEN OA

Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

Children's Hospital Colorado · University of Colorado Denver · +10 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

311
total citations
FWCI
63.63
Percentile
100%
References
40
Citations per year

Authors

20

Topics & keywords

Keywords
  • Palivizumab
  • Medicine
  • Gestational age
  • Placebo
  • Pediatrics
  • Regimen
  • Bronchopulmonary dysplasia
  • Bronchiolitis
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding